Alcohol drinking is reduced by a 1 -but not by a -opioid receptor antagonist in alcohol-preferring rats

By Honkanen A.   Vilamo L.   Wegelius K.   Sarviharju M.   Hyytia P.   Korpi E.R.  

European Journal of Pharmacology, Vol. 304, Iss. 1, 1996-05 ,pp. : 7-13

Elsevier

Access to resources Recommend Favorite

Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB 1 receptor antagonist, SR 141716

By Vacca G.   Serra S.   Brunetti G.   Carai M.A.M.   Gessa G.L.   Colombo G.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 55-59

Elsevier

Access to resources Recommend Favorite

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A

By Aceto M.D.   Scates S.M.   Lowe J.A.   Martin B.R.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB₁ receptor antagonist

By Järbe Torbjörn   Harris Michele   Li Chen   Liu Qian   Makriyannis Alexandros  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats

By Rowland Neil   Mukherjee Monica   Robertson Kimberly  

Psychopharmacology, Vol. 159, Iss. 1, 2001-12 ,pp. : 111-116

Springer Publishing Company

Access to resources Recommend Favorite